TG4010 immunotherapy combined with first-line therapy in advanced non-small cell lung cancer (NSCLC): phase IIb results of the TIME study

by Quoix, Elisabeth, Sequist, Lecia, Nemunaitis, John, Beck, Thaddeus, Jaskiewicz, Piotr, Oster, Jean-Philippe, Scherpereel, Arnaud, Juhász, Erzsébet, Mark, Zsuzsanna, Alvarez, Rosa, Waqar, Saiama, Potz, Joseph, Vrindavanam, Nandagopal, Melnyk, Anton, Ross, Helen, Limacher, Jean-Marc
Published 2014